Market Dynamics
The Indonesia apigenin market is expected to be driven by the increasing use of apigenin-based dietary and pharmacological supplements in the pharmaceutical and cosmetic industries as a direct result of its anti-allergic, anti-inflammatory and antioxidant properties. As a natural bioactive compound, apigenin has been clinically proven to offer a range of therapeutic benefits through its highly efficient properties, which can help in the treatment of a wide range of ailments and diseases, including cancer and diabetes. The growing demand for cosmetic products containing apigenin has been on an upward trajectory in the country in recent years, as there is an increasing awareness about the advantages of apigenin in maintaining a healthy complexion for healthy looking skin and to reduce the signs of aging. People of all age groups are increasingly realizing the importance of using natural products for skincare, such as apigenin, instead of chemical-based ones, resulting in this trend being further fueled by health-conscious individuals. It is expected that the rising demand from the pharmaceutical and cosmetic industry will drive the Indonesia apigenin market from 2018 to 2032.
Government initiatives in the health sector, such as the availability of affordable pharmaceuticals, are also expected to fuel the demand for apigenin-based products and services in Indonesia during the projection period, further driving the growth of the apigenin market. Moreover, technological advancements are also enabling the production of flavor-stable and safe apigenin-based products, such as food and beverages. In addition to the demand drivers, certain regulatory challenges in the industry, such as stringent quality control and laboratory tests, are expected to be an impediment for the production of apigenin-based products. Nonetheless, with increasing awareness among consumers, the Indonesia apigenin market is likely to keep expanding in the forecasted period.
